• Mitochondrial ROS-Linked Apoptosis and Muscle Atrophy in Ova

  2026-05-09

  This study investigates the role of mitochondrial reactive oxygen species (ROS) in driving apoptosis and necroptosis during muscle atrophy in metastatic ovarian cancer. By targeting mitochondrial ROS with SkQ1, the authors reveal that suppressing apoptotic caspase activity does not prevent muscle atrophy, challenging prevailing assumptions about cell death pathways in cancer cachexia.

• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-Catenin

  2026-05-08

  This study uncovers how matrix metalloproteinase 7 (MMP7) promotes liver fibrosis in biliary atresia (BA) by inducing epithelial–mesenchymal transition (EMT) through the E-cadherin/β-catenin signaling pathway. The findings offer mechanistic insights and highlight the therapeutic potential of directly targeting MMP7 or downstream β-catenin activity in fibrotic liver disease.

• Amphotericin B: Applied Protocols for Fungal Infection Resea

  2026-05-07

  Leverage Amphotericin B’s potent antifungal activity for robust cell-based and mechanistic assays. This guide details experimental workflows, troubleshooting strategies, and protocol enhancements, enabling reproducible and insightful outcomes in fungal infection research.

• Azithromycin: Mechanistic Advances and Translational Impact

  2026-05-07

  This article delivers a strategic, evidence-based perspective on the use of Azithromycin—a potent macrolide antibiotic—in bacterial infection research and trypanosomosis models. We bridge mechanistic insight with actionable experimental guidance, contextualize APExBIO’s offering within the competitive landscape, and provide protocol benchmarks, translational context, and a forward-looking outlook for translational researchers.

• Tomentodione M Reverses Docetaxel Resistance via P-gp/p38 MA

  2026-05-06

  This study demonstrates that tomentodione M, a natural meroterpenoid, sensitizes multidrug-resistant cancer cells to chemotherapeutic agents such as Docetaxel by downregulating P-glycoprotein through inhibition of p38 MAPK signaling. The findings offer a mechanistic rationale for targeting the P-gp/p38 MAPK axis to overcome clinical drug resistance, providing a foundation for future cancer chemotherapy research.

• Practical Guide to Oligo (dT) 25 Beads for mRNA Purification

  2026-05-06

  Oligo (dT) 25 Beads enable efficient and selective eukaryotic mRNA isolation by targeting polyA tails, supporting downstream applications such as RT-PCR and sequencing. This product is best suited for workflows requiring high-purity mRNA from total RNA or cell lysates, but is not recommended for non-polyadenylated RNA species or prokaryotic samples.

• Optimizing Bioluminescent Assays with EZ Cap™ Firefly Lucife

  2026-05-05

  Explore how Firefly Luciferase mRNA with 5-moUTP modification advances assay sensitivity, mRNA stability, and immune evasion. This article uncovers practical innovations and comparative insights beyond existing reviews.

• Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via Col

  2026-05-05

  This study identifies mitochondrial NAD+ deficiency in vascular smooth muscle as a direct driver of thoracic and abdominal aortic aneurysm through impaired collagen III turnover. Multiomics and genetic analyses reveal SLC25A51-regulated mitochondrial NAD+ homeostasis as a critical determinant of proline biosynthesis and aortic wall stability, providing new mechanistic insight and highlighting potential molecular targets for future therapeutic strategies.

• (S)-(+)-Ibuprofen: Advanced COX Inhibitor Use in Lab Researc

  2026-05-04

  (S)-(+)-Ibuprofen offers high selectivity and reproducibility for inflammation pathway research, outperforming racemic mixtures in precision and tolerability. This guide translates cutting-edge findings into actionable protocols, troubleshooting insights, and advanced applications, empowering researchers to achieve robust, reproducible results in both in vitro and in vivo settings.

• D-Luciferin (Potassium Salt): Precision Imaging in Brain Tum

  2026-05-04

  Explore how D-Luciferin potassium salt enables high-sensitivity in vivo bioluminescence imaging for brain tumor research. This article delivers advanced insight into BBB-penetrant applications, practical assay design, and translational strategy.

• TRIM66 as an Epigenetic Repressor in Olfactory Receptor Choi

  2026-05-03

  This study identifies TRIM66 as a crucial epigenetic repressor that governs monogenic olfactory receptor expression in mice. The findings clarify how single olfactory sensory neurons restrict expression to one receptor, with implications for understanding sensory coding and epigenetic regulation.

• Adefovir (SKU C6629): Reliable Antiviral for HBV Research Wo

  2026-05-02

  This article addresses common laboratory challenges in hepatitis B virus (HBV) research, focusing on rigorous, scenario-driven solutions using Adefovir (SKU C6629). It covers experimental design, protocol optimization, and product reliability, providing quantitative evidence and actionable recommendations for biomedical scientists seeking reproducible, high-sensitivity results.

• 3D Organoid-CAF Co-Cultures Reveal Chemoresistance Mechanism

  2026-05-02

  Schuth et al. developed a patient-specific three-dimensional co-culture model of pancreatic cancer organoids and matched cancer-associated fibroblasts (CAFs), uncovering how stromal interactions fuel chemoresistance. Their work highlights the role of CAF-driven epithelial-to-mesenchymal transition and pro-inflammatory signaling in reducing chemotherapy efficacy, offering new insights for personalized oncology approaches.

• Protease Inhibitor Cocktail (EDTA-Free): Data-Driven Lab Sol

  2026-05-01

  This article explores real laboratory scenarios where the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO; SKU K4002) resolves common challenges in protein stability, data reproducibility, and workflow efficiency. Drawing on recent research and practical optimization, it demonstrates how this APExBIO reagent supports rigorous, reproducible protein science for cell viability and cytotoxicity assays.

• Dopamine Inhibits Osteoclastogenesis via cAMP/PKA/CREB Pathw

  2026-04-30

  Wang et al. reveal that dopamine suppresses osteoclast differentiation by inhibiting the cAMP/PKA/CREB signaling cascade in bone cells. This mechanistic insight advances our understanding of neural regulation in bone remodeling and suggests new directions for dissecting neurotransmitter-controlled bone metabolism.

16487 records 10/1100 page Previous Next First page 上5页 678910 下5页 Last page